Joseph J. Larosa - 07 Apr 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP General Counsel and Secret
Signature
/s/**Joseph LaRosa
Issuer symbol
REGN
Transactions as of
07 Apr 2022
Net transactions value
-$3,687,705
Form type
4
Filing time
11 Apr 2022, 16:41:26 UTC
Previous filing
04 Apr 2022
Next filing
12 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale $3,687,705 -5,114 -23% $721.10 16,900 07 Apr 2022 Direct F1, F2
holding REGN Common Stock 2,109 07 Apr 2022 2021 GRAT
holding REGN Common Stock 314 07 Apr 2022 By 401(k) Plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 5,114 shares of Company stock on April 7, 2022 at prices ranging from $721.10 to $721.13. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 7, 2022 at each separate price.